跳至主要内容
临床试验/NCT04599348
NCT04599348Unknown早期 1 期

Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

Practitioners Alliance Network2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2020年10月14日最近更新:
适应症

试验速览

阶段
早期 1 期
发起方
入组人数
70
试验地点
2
主要终点
Composite Visual analog scale of symptoms

研究概览

简要总结

Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome and fibromyalgia?

详细描述

Ginseng has been shown in earlier studies to help fatigue in a number of conditions. But because of overharvesting, most ginseng is no longer have optimal levels of the active ginsenosides. A new technique has been developed to restore the level of active ginseng components those found in the wild ginseng used in earlier studies. This is available in a form called HRG 80 Red Ginseng.

The study is an open pilot study to explore whether this treatment would be helpful for improving clinical function and symptomatology in chronic fatigue syndrome and fibromyalgia. Current clinical experience is suggesting that it may be.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be diagnosed with CFS and/or fibromyalgia
  • live in the United States 3 - be over 18 years of age

排除标准

  • Pregnancy

结局指标

主要结局

Composite Visual analog scale of symptoms

时间窗: 6 weeks

Composite Score visual analog scale (0 - 30 Visual analog scale units , with 30 VAS units representing optimal function) of energy, cognition, and overall well-being. Each on a 0-10 scale with 10 being healthy. The units are the same for all 3 allowing them to be combined into a single composite total score. This total score (0-30 with 30 being the best outcome ) is the primary outcome measure

次要结局

  • VAS of pain and sleep(6 weeks)

研究者

发起方
Practitioners Alliance Network
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacob Teitelbaum

Principal investigator

Practitioners Alliance Network

研究点 (2)

Loading locations...

相似试验